{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "DJ-1 has cytoprotective activity against oxidative stress and is involved in suppression of Daxx translocation.",
          "judgment": "Yes",
          "reasoning": "The paper defines DJ-1's role in oxidative stress protection and Daxx translocation suppression, which are mechanisms relevant to Parkinson's disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "DJ-1 Ϫ/Ϫ MEFs were stably transfected with DJ-1 constructs and exposed to H2O2 to measure cytoprotective activity by LDH release. DJ-1 Ϫ/Ϫ MEF cells were also used to study Daxx translocation.",
          "judgment": "Yes",
          "reasoning": "The assays measuring cytoprotective activity against oxidative stress and Daxx translocation directly model DJ-1's known biological functions and are relevant to Parkinson's disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study included wild-type DJ-1 as a control, and indicates that results are representative of two independent experiments with error bars showing standard deviation of triplicate samples.",
          "judgment": "Yes",
          "reasoning": "Both wild-type control and null (vector control) were used, and the paper explicitly states that experiments were performed in triplicate with results from two independent experiments.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The text doesn't explicitly mention the use of previously classified pathogenic or benign variants as controls.",
          "judgment": "No",
          "reasoning": "There is no mention of known pathogenic or benign variants being used as controls in the assay.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports statistical significance with p-values (p Ͻ 0.05; p Ͻ 0.001) but does not calculate or report OddsPath.",
          "judgment": "No",
          "reasoning": "While basic statistical significance is reported (p-values), there is no calculation or reporting of OddsPath for this variant.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The text doesn't provide information about the total number of benign/pathogenic variant controls used across the entire study.",
          "judgment": "No",
          "reasoning": "There is insufficient information in the text to determine the total number of control variants used in the study.",
          "next_step_or_outcome": "Proceed to final evidence strength determination"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting",
        "reasoning": "The functional evidence reaches the supporting level as it has basic controls and replicates but lacks variant controls and OddsPath calculation."
      },
      "overall_conclusion": "The M26I mutation shows reduced DJ-1 cytoprotective activity and loss of suppression of Daxx translocation, which are relevant to Parkinson's disease pathogenesis. The assay had proper controls and replicates but lacked variant controls and OddsPath calculation, resulting in a PS3_supporting classification."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C",
          "alt": "A",
          "position": "106"
        },
        "variant_string_id": "DJ-1 C106A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "DJ-1 has cytoprotective activity against oxidative stress and is involved in suppression of Daxx translocation.",
          "judgment": "Yes",
          "reasoning": "The paper defines DJ-1's role in oxidative stress protection and Daxx translocation suppression, which are mechanisms relevant to Parkinson's disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "DJ-1 Ϫ/Ϫ MEFs were stably transfected with DJ-1 constructs and exposed to H2O2 to measure cytoprotective activity by LDH release.",
          "judgment": "Yes",
          "reasoning": "The assay measuring cytoprotective activity against oxidative stress directly models DJ-1's known biological function and is relevant to Parkinson's disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study included wild-type DJ-1 as a control, and indicates that results are representative of two independent experiments with error bars showing standard deviation of triplicate samples.",
          "judgment": "Yes",
          "reasoning": "Both wild-type control and null (vector control) were used, and the paper explicitly states that experiments were performed in triplicate with results from two independent experiments.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The text doesn't explicitly mention the use of previously classified pathogenic or benign variants as controls.",
          "judgment": "No",
          "reasoning": "There is no mention of known pathogenic or benign variants being used as controls in the assay.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports statistical significance with p-values (p Ͻ 0.05; p Ͻ 0.001) but does not calculate or report OddsPath.",
          "judgment": "No",
          "reasoning": "While basic statistical significance is reported (p-values), there is no calculation or reporting of OddsPath for this variant.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The text doesn't provide information about the total number of benign/pathogenic variant controls used across the entire study.",
          "judgment": "No",
          "reasoning": "There is insufficient information in the text to determine the total number of control variants used in the study.",
          "next_step_or_outcome": "Proceed to final evidence strength determination"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting",
        "reasoning": "The functional evidence reaches the supporting level as it has basic controls and replicates but lacks variant controls and OddsPath calculation."
      },
      "overall_conclusion": "The C106A mutation shows reduced DJ-1 cytoprotective activity against oxidative stress, which is relevant to Parkinson's disease pathogenesis. The assay had proper controls and replicates but lacked variant controls and OddsPath calculation, resulting in a PS3_supporting classification."
    }
  ]
}